Early Menopause — Caused by Cancer Treatment

Whether periods return depends on the treatment type, the dose, and your age at the time. Younger women with a larger ovarian reserve are more likely to see periods return after chemotherapy than older women. Pelvic radiation frequently causes permanent menopause, and surgical removal of the ovaries always does. Periods can return months or even a couple of years after chemotherapy finishes, which makes it difficult to give a definitive answer immediately after treatment ends. Blood tests can monitor ovarian function over time, and your oncologist will advise based on those results.

This depends entirely on your cancer type and does not have a universal answer. For most cancers that are not hormone-sensitive — certain lung cancers, cervical cancers, and sarcomas — hormone therapy for menopausal symptoms is not automatically ruled out. For hormone receptor-positive breast cancer, most oncologists advise against systemic oestrogen, though some local vaginal preparations may be considered on an individual basis. Never start or stop hormone therapy without discussing it with your treating oncologist, because the answer is specific to your diagnosis and your current treatment status.

If treatment has permanently stopped your ovaries from working, natural conception will not be possible. If you had eggs or embryos frozen before treatment, those may be used through IVF, depending on whether your uterus was affected by treatment. If your periods return after chemotherapy, natural conception may be possible once your oncologist confirms it is safe to try. The waiting period after treatment is for your benefit and the safety of a potential pregnancy — it is not an arbitrary delay. Discuss your specific situation with both your oncologist and a fertility specialist.

Oestrogen plays a central role in maintaining bone density. When menopause occurs early — particularly before age 45 — the risk of osteoporosis accumulates over more years than it would with natural menopause in the 50s. Your oncologist may recommend a DEXA scan to measure bone density and advise on calcium, vitamin D supplementation, and, if needed, medication to protect the bones. Weight-bearing exercise also helps maintain bone strength. This is a long-term survivorship issue worth raising at your annual follow-up appointments, not only during active treatment.

GnRH agonists temporarily suppress ovarian activity during chemotherapy, with the aim of reducing the ovaries' exposure to the drugs. ASCO acknowledges this as an option to discuss with your oncologist, but notes that the evidence on whether they preserve future fertility is still developing. They are not considered a reliable substitute for egg or embryo freezing before treatment begins. Whether they are appropriate for your cancer type and treatment plan is a question for your oncologist to answer before chemotherapy starts — not at a later stage when options have already narrowed.

Most information about menopause is written for women going through it naturally in their late 40s or early 50s, gradually, over several years. Treatment-induced menopause in a younger woman is different in several important ways: it often arrives suddenly, symptoms can be more intense, the effect on fertility is immediate rather than gradual, and the long-term health risks from an extended period of low oestrogen — including cardiovascular risk and osteoporosis — are greater because they accumulate over more years. A gynaecologist or menopause specialist experienced with cancer survivors will give you more relevant guidance than resources written for older women going through natural menopause.